Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Technology Scientific & Technical Instruments
Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Therma Bright Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(417)
•••
Post by Zimmee1on Sep 10, 2021 10:55am
80 Views
Post# 33839652

Will she hit and maintain $0.51 today?

Will she hit and maintain $0.51 today?
Recent Trades - Last 10 of 171
Time ET Ex Price Change Volume Buyer Seller Markers
10:39:09 M 0.50 0.015 30 80 National Bank 80 National Bank E
10:38:43 M 0.50 0.015 200 80 National Bank 80 National Bank  
10:38:39 U 0.495 0.01 1,000 7 TD Sec 2 RBC K
10:37:15 M 0.50 0.015 460 7 TD Sec 7 TD Sec E
10:37:06 A 0.495 0.01 2,000 19 Desjardins 79 CIBC K
10:36:27 V 0.495 0.005 467 9 BMO Nesbitt 62 Haywood  
10:36:27 V 0.49 0.005 29,500 7 TD Sec 7 TD Sec K
10:36:27 V 0.49 0.005 500 7 TD Sec 7 TD Sec K
10:35:26 V 0.495 0.01 1,500 9 BMO Nesbitt 1 Anonymous K


Realtime quote for V:THRM as of 10:51:46 EDT
You have been charged 2.0¢ C

10:51:46 EDT Fri 10 Sep 2021

 

V:THRM - THERMA BRIGHT INC - https://www.thermabright.com 10:51:46 EDT -
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
THRM - V   29.0 0.49 · 0.50 95.0 0.495 +0.01 2.1 474.2 228 196 0.48  0.50  0.47 1.05  0.065 10:50:54 Sep 08 realtime
TSX-V - V 29.0 0.49 · 0.50 95.0 0.495 +0.01 2.1 325.4 157 132 0.48  0.50  0.47 1.05  0.065 10:50:54   realtime
NEO ATS - U   0.49 +0.005 1.0 15.0 7 4 0.47  0.49  0.47   10:29:02   15 min
Alpha - A   0.495 +0.01 2.1 70.0 34 8 0.475  0.495  0.47   10:29:03   15 min
Omega - O   0.49 +0.005 1.0 15.5 8 6 0.48  0.49  0.48   10:29:02   15 min
Chi-X - X   0.49 +0.005 1.0 7.5 4 6 0.48  0.49  0.48   10:29:02   15 min
CX2 - H   0.49 +0.005 1.0 36.0 17 16 0.47  0.49  0.47   10:29:02   15

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities